Literature DB >> 23993434

Total joint arthroplasty readmission rates and reasons for 30-day hospital readmission.

Victoria Avram1, Danielle Petruccelli2, Mitch Winemaker1, Justin de Beer1.   

Abstract

Given institutional pressures to reduce hospital length of stay (LOS) we hypothesized that "failure to cope" would be a significant factor for readmission following total joint arthroplasty (TJA). A retrospective review of 4288 TJA patients was conducted to determine readmission rates and reasons for readmit within 30 days of discharge. Ninety-five patients (2.2%; 95% CI: 1.8%-2.7%) were readmitted. Leading diagnoses were surgical site infection (23.2%) and cardiovascular event (16.8%). Of readmits 5.3% (5/95) were readmitted for failure to cope, representing 0.1% of the sample. In multivariate analysis, increased age was a significant predictor of readmission (OR = 0.974, 95% CI 0.952-0.997). Contrary to our hypothesis failure to cope was not a leading diagnosis for readmission; concerns remain that early discharge may however correlate with increased readmit rates.
© 2013.

Entities:  

Keywords:  acute hospital length of stay; hip arthroplasty; knee arthroplasty; readmission rate; total joint arthroplasty

Mesh:

Year:  2013        PMID: 23993434     DOI: 10.1016/j.arth.2013.07.039

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  32 in total

1.  Association of Pain on Hospital Discharge with the Risk of 30-Day Readmission in Patients with Total Hip and Knee Replacement.

Authors:  Ickpyo Hong; Jordan R Westra; James S Goodwin; Amol Karmarkar; Yong-Fang Kuo; Kenneth J Ottenbacher
Journal:  J Arthroplasty       Date:  2020-07-03       Impact factor: 4.757

2.  Are There Modifiable Risk Factors for Hospital Readmission After Total Hip Arthroplasty in a US Healthcare System?

Authors:  Elizabeth W Paxton; Maria C S Inacio; Jasvinder A Singh; Rebecca Love; Stefano A Bini; Robert S Namba
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

3.  CORR Insights®: Are Readmissions After THA Preventable?

Authors:  Rajiv Gandhi
Journal:  Clin Orthop Relat Res       Date:  2017-02-24       Impact factor: 4.176

4.  Are Readmissions After THA Preventable?

Authors:  Douglas S Weinberg; Matthew J Kraay; Steven J Fitzgerald; Vasu Sidagam; Glenn D Wera
Journal:  Clin Orthop Relat Res       Date:  2016-11-11       Impact factor: 4.176

5.  All-Cause Versus Complication-Specific Readmission Following Total Knee Arthroplasty.

Authors:  Michele D'Apuzzo; Geoffrey Westrich; Chisa Hidaka; Ting Jung Pan; Stephen Lyman
Journal:  J Bone Joint Surg Am       Date:  2017-07-05       Impact factor: 5.284

6.  Readmission Rates and Diagnoses Following Total Hip Replacement in Relation to Insurance Payer Status, Race and Ethnicity, and Income Status.

Authors:  Robert S White; Dahniel L Sastow; Licia K Gaber-Baylis; Virginia Tangel; Andrew D Fisher; Zachary A Turnbull
Journal:  J Racial Ethn Health Disparities       Date:  2018-02-12

7.  Predictive factors of length of hospital stay after primary total knee arthroplasty.

Authors:  Lotte van den Belt; Peter van Essen; Petra J C Heesterbeek; Koen C Defoort
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-09-20       Impact factor: 4.342

8.  Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?

Authors:  Steven M Kurtz; Edmund C Lau; Kevin L Ong; Edward M Adler; Frank R Kolisek; Michael T Manley
Journal:  Clin Orthop Relat Res       Date:  2017-12       Impact factor: 4.176

9.  Predictors and Cost of Readmission in Total Knee Arthroplasty.

Authors:  Kenneth L Urish; Yongmei Qin; Benjamin Y Li; Tudor Borza; Michael Sessine; Peter Kirk; Brent K Hollenbeck; Jonathan E Helm; Mariel S Lavieri; Ted A Skolarus; Bruce L Jacobs
Journal:  J Arthroplasty       Date:  2018-04-17       Impact factor: 4.757

10.  Joint arthroplasty Perioperative Surgical Home: Impact of patient characteristics on postoperative outcomes.

Authors:  Duy L Phan; Kyle Ahn; Joseph B Rinehart; Michael-David Calderon; Wei-Der Wu; Ran Schwarzkopf
Journal:  World J Orthop       Date:  2016-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.